endocrinology Archives -

Merck KGaA has forged a second partnership in the bioelectronics category in two weeks, teaming up with Innervia

Merck makes another bioelectronics play, partnering with Innervia

https://pharmaphorum.com/news/merck-makes-another-bioelectronics-play-partnering-innervia/

US healthcare group Carbon Health has made a move into digital care for patients with chronic conditions, buying

Carbon Health buys virtual diabetes clinic firm Steady Health

https://pharmaphorum.com/news/carbon-health-buys-virtual-diabetes-clinic-firm-steady-health/

The EU regulator has started the clock ticking on its review of Pfizer and Astellas’ prostate cancer drug

EMA starts review of Xtandi in hormone-sensitive prostate cancer

https://pharmaphorum.com/news/ema-starts-review-of-xtandi-in-hormone-sensitive-prostate-cancer/

South Korean firm looking to develop novel drugs

Samsung Bioepis signs R&D agreement with Takeda

https://pharmaphorum.com/news/samsung-bioepis-signs-rd-agreement-takeda/

Drug could be filed after “outlier” analysis.

Growth hormone could be filed without further trials, says OPKO

https://pharmaphorum.com/news/opko-growth-hormone-filed-without-trials/

US biotech OPKO Health has said it will continue with clinical development of its long-acting human growth hormone

OPKO weekly growth hormone jab fails in phase 3

https://pharmaphorum.com/news/opko-weekly-growth-hormone-jab-fails-in-phase-3/

endocrinology